Alvotech (ALVOW) Competitors

$0.25 0.00 (0.00%)

As of 05/13/2026

ALVOW vs. AIMDW, ARAV, ACABW, RNA, and BFRIW

Should you buy Alvotech stock or one of its competitors? MarketBeat compares Alvotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alvotech include Ainos (AIMDW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Avidity Biosciences (RNA), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Alvotech compare to Ainos?

Ainos (NASDAQ:AIMDW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$124.16K	N/A	N/A	N/A	N/A
Alvotech	$586.32M	N/A	N/A	N/A	N/A

In the previous week, Alvotech had 1 more articles in the media than Ainos. MarketBeat recorded 2 mentions for Alvotech and 1 mentions for Ainos. Ainos' average media sentiment score of 1.89 beat Alvotech's score of 1.44 indicating that Ainos is being referred to more favorably in the media.

Company	Overall Sentiment
Ainos	Very Positive
Alvotech	Positive

Summary

Alvotech beats Ainos on 2 of the 3 factors compared between the two stocks.

How does Alvotech compare to Aravive?

Aravive (NASDAQ:ARAV) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
Alvotech	$586.32M	N/A	N/A	N/A	N/A

In the previous week, Alvotech had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for Aravive. Alvotech's average media sentiment score of 1.44 beat Aravive's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Aravive	Neutral
Alvotech	Positive

Summary

Alvotech beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Alvotech compare to Atlantic Coastal Acquisition Corp. II?

Alvotech (NASDAQ:ALVOW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

In the previous week, Alvotech had 2 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for Atlantic Coastal Acquisition Corp. II. Alvotech's average media sentiment score of 1.44 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Atlantic Coastal Acquisition Corp. II	Neutral

Summary

Alvotech beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to Avidity Biosciences?

Alvotech (NASDAQ:ALVOW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Alvotech has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Alvotech's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Avidity Biosciences	-3,650.39%	-44.92%	-39.57%

Avidity Biosciences has a consensus price target of $69.42, indicating a potential upside of 418.07%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Avidity Biosciences is more favorable than Alvotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alvotech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Avidity Biosciences	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.32

Alvotech has higher revenue and earnings than Avidity Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Avidity Biosciences	$18.62M	N/A	-$322.30M	N/A	N/A

In the previous week, Alvotech had 1 more articles in the media than Avidity Biosciences. MarketBeat recorded 2 mentions for Alvotech and 1 mentions for Avidity Biosciences. Alvotech's average media sentiment score of 1.44 beat Avidity Biosciences' score of 0.94 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Avidity Biosciences	Positive

Summary

Alvotech beats Avidity Biosciences on 6 of the 10 factors compared between the two stocks.

How does Alvotech compare to Biofrontera?

Alvotech (NASDAQ:ALVOW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Biofrontera	$41.71M	N/A	N/A	N/A	N/A

In the previous week, Alvotech had 1 more articles in the media than Biofrontera. MarketBeat recorded 2 mentions for Alvotech and 1 mentions for Biofrontera. Biofrontera's average media sentiment score of 1.87 beat Alvotech's score of 1.44 indicating that Biofrontera is being referred to more favorably in the news media.

Company	Overall Sentiment
Alvotech	Positive
Biofrontera	Very Positive

Summary

Alvotech beats Biofrontera on 2 of the 3 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALVOW vs. The Competition

Export

Metric	Alvotech	Drug Manufacturers Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$2.10B	$6.29B	$12.48B
Dividend Yield	N/A	2.97%	2.79%	5.30%
P/E Ratio	N/A	5.31	20.91	25.60
Price / Sales	N/A	1,460.22	548.78	75.41
Price / Cash	N/A	10.18	42.94	55.34
Price / Book	N/A	10.89	9.87	6.72
Net Income	N/A	$20.70B	$3.55B	$333.73M
7 Day Performance	21.54%	0.29%	-0.24%	0.38%
1 Month Performance	N/A	-1.79%	1.44%	4.02%
1 Year Performance	-85.88%	26.94%	41.01%	36.37%

Alvotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALVOW Alvotech	N/A	$0.25 flat	N/A	-86.0%	$0.00	$586.32M	N/A	4	Short Interest Decrease Gap Up
AIMDW Ainos	N/A	$0.11 flat	N/A	-21.3%	$0.00	$124.16K	N/A	40
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15
RNA Avidity Biosciences	1.9871 of 5 stars	$13.41 +5.0%	$69.42 +417.7%	-55.5%	$0.00	$18.62M	N/A	190

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALVOW) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alvotech (ALVOW) Competitors

ALVOW vs. AIMDW, ARAV, ACABW, RNA, and BFRIW

How does Alvotech compare to Ainos?

Summary

How does Alvotech compare to Aravive?

Summary

How does Alvotech compare to Atlantic Coastal Acquisition Corp. II?

Summary

How does Alvotech compare to Avidity Biosciences?

Summary

How does Alvotech compare to Biofrontera?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALVOW vs. The Competition

Alvotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alvotech (ALVOW) Competitors

ALVOW vs. AIMDW, ARAV, ACABW, RNA, and BFRIW

How does Alvotech compare to Ainos?

Is AIMDW or ALVOW more profitable?

Which has better earnings and valuation, AIMDW or ALVOW?

Does the media refer more to AIMDW or ALVOW?

Summary

How does Alvotech compare to Aravive?

Is ARAV or ALVOW more profitable?

Do insiders & institutionals hold more shares of ARAV or ALVOW?

Which has higher earnings and valuation, ARAV or ALVOW?

Does the media refer more to ARAV or ALVOW?

Summary

How does Alvotech compare to Atlantic Coastal Acquisition Corp. II?

Is ALVOW or ACABW more profitable?

Which has preferable valuation and earnings, ALVOW or ACABW?

Does the media refer more to ALVOW or ACABW?

Summary

How does Alvotech compare to Avidity Biosciences?

Is ALVOW or RNA more profitable?

Do analysts recommend ALVOW or RNA?

Which has higher valuation & earnings, ALVOW or RNA?

Does the media favor ALVOW or RNA?

Summary

How does Alvotech compare to Biofrontera?

Is ALVOW or BFRIW more profitable?

Which has stronger valuation and earnings, ALVOW or BFRIW?

Does the media refer more to ALVOW or BFRIW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALVOW vs. The Competition

Alvotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools